Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Locally Advanced Malignant Neoplasm|Breast Cancer
Interventions: DRUG: Propranolol|OTHER: DOT imaging|DRUG: Paclitaxel|DRUG: Nab-paclitaxel|DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Doxorubicin|DRUG: Cyclophosphamide|PROCEDURE: Surgery|DRUG: Premedication|DRUG: Anti-nausea therapy|DRUG: Pegfilgrastim
Sponsor: Columbia University